National Research Corporation reported a 5% increase in revenue to $35.5 million and a 7% increase in operating income to $12.0 million for the first quarter of 2021. The company's focus remains on organic growth and strategic M&A activity.
Total Recurring Contract Value growth of 6% to $149.5 million.
Revenue increased 5% to $35.5 million.
Operating Income increased 7% to $12.0 million.
Acquired the intellectual property of PatientWisdom to add value to clients.
The company expects to leverage available liquidity and strong free cash flow to support additional M&A activity and provide returns to shareholders through dividends.
Analyze how earnings announcements historically affect stock price performance